Breyanzi is an FDA-approved prescription drug for the treatment of adults with relapsed or refractory large B-cell lymphoma who have been treated with at least 2 prior therapies.

Polivy is indicated for the treatment of diffuse large B-cell lymphoma after at least two other cancer treatments have failed. Polivy is often used in combination with Bentamamine (Bendeka, Treanda) and Rituximab (Rituxan) in the treatment of adult diffuse large B-cell lymphoma after at least 2 failed previous regimens. .